Browse

You are looking at 551 - 600 of 886 items for

  • Refine by Access: All content x
Clear All
Restricted access

Student Pharmacist Drug Testing (1826)

Edited by Bruce Hawkins

Restricted access

Suicide Awareness and Prevention (1901)

Edited by Bruce Hawkins

Restricted access

Support for FDA Expanded Access (Compassionate Use) Program (1508)

Edited by Bruce Hawkins

Restricted access

Support for Second Victims (1524)

Edited by Bruce Hawkins

Restricted access

Tamper-Evident Packaging on Topical Products (9211)

Edited by Bruce Hawkins

Restricted access

Technician-Checking-Technician Programs (0310)

Edited by Bruce Hawkins

Restricted access

Therapeutic and Psychosocial Considerations of Transgender Patients (1718)

Edited by Bruce Hawkins

Restricted access

Therapeutic Indication in Clinical Decision Support Systems (1608)

Edited by Bruce Hawkins

Restricted access

Therapeutic Interchange (8708)

Edited by Bruce Hawkins

Restricted access

Therapeutic Monitoring of Vancomycin in Adult Patients: A Consensus Review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists

Edited by Bruce Hawkins

Restricted access

Therapeutic Use of Cannabidiol (1910)

Edited by Bruce Hawkins

Restricted access

Timely Board of Pharmacy Licensing (1621)

Edited by Bruce Hawkins

Restricted access

Tobacco, Tobacco Products, and Electronic Delivery Systems (1625)

Edited by Bruce Hawkins

Restricted access

Transitions of Care (1208)

Edited by Bruce Hawkins

Restricted access

Unit Dose Packaging Availability (1801)

Edited by Bruce Hawkins

Restricted access

Universal Influenza Vaccination (0601)

Edited by Bruce Hawkins

Restricted access

Use of Biomarkers in Clinical Practice (1824)

Edited by Bruce Hawkins

Restricted access

Use of Closed-System Transfer Devices to Reduce Drug Waste (1813)

Edited by Bruce Hawkins

Restricted access

Use of Color to Identify Drug Products (9608)

Edited by Bruce Hawkins

Restricted access

Use of International System of Units for Patient- and Medication-related Measurements (1811)

Edited by Bruce Hawkins

Restricted access

Use of Methadone to Treat Pain (1607)

Edited by Bruce Hawkins

Restricted access

Use of Surrogate Endpoints for FDA Approval of Drug Uses (1011)

Edited by Bruce Hawkins

Restricted access

Use of Two Patient Identifiers in the Outpatient Setting (1024)

Edited by Bruce Hawkins

Restricted access

Value-Based Purchasing (1209)

Edited by Bruce Hawkins

Restricted access

Workforce Diversity (1705)

Edited by Bruce Hawkins

Restricted access

Workload Monitoring and Reporting (0901)

Edited by Bruce Hawkins

Restricted access

Chapter 1 Ambulatory Pharmacists and Their Responsibilities in New Healthcare Models

Mary Ann Kliethermes, Kelly T. Epplen, and Starlin Haydon-Greatting

Restricted access

Chapter 9 The Art of Pharmacist-Provided Patient Care

Mary Ann Kliethermes

Restricted access
Cover Building a Successful Ambulatory Care Practice

Building a Successful Ambulatory Care Practice

Advancing Patient Care

Edited by Mary Ann Kliethermes and Tim R. Brown

Restricted access

Chapter 5 Creating the Ambulatory Patient Care Model

Michelle L. Cudnik and Kristina L. Butler

Restricted access

Chapter 7 Generating Revenue Through Healthcare Reimbursement

Betsy Bryant Shilliday, Jamie J. Cavanaugh, and Sandra Leal

Restricted access

Chapter 4 Marketing Your Ambulatory Practice

Tim R. Brown, Mary Ann Kliethermes, and Nasir Salim

Restricted access

Chapter 6 Optimal Use of Informational Technology

Samm Anderegg and Shelly Spiro

Restricted access

Chapter 2 Planning and Steps to Building the Ambulatory Practice Model

Christie Schumacher and Elizabeth Van Dril

Restricted access

Chapter 3 Preparing a Business Plan for an Ambulatory Practice

Erika Smith, Spencer Crook, and Nasir Salim

Restricted access

Chapter 8 Value and Quality for Ambulatory Pharmacist Patient Care Practice

Mary Ann Kliethermes

Restricted access
Cover Biosimilars & Biologics

Biosimilars & Biologics

Implementation and Monitoring in a Healthcare Setting

Edited by Steven Lucio

Restricted access

Chapter 1: A New Type of Blockbuster: The Growth of Biologics

Edited by Steven Lucio

Restricted access

Chapter 10: Defining Biosimilar Value and Other Seemingly Impossible Tasks

Edited by Steven Lucio

Restricted access

Chapter 11: Biosimilar Formulary Management Strategies

Edited by Steven Lucio

Restricted access

Chapter 2: Déjà Vu or Something New?–Comparing the Generic and Biosimilar Experiences

Edited by Steven Lucio

Restricted access

Chapter 3: Bugs and Drugs, and Yeast and Mice, and Chinese Hamsters

Edited by Steven Lucio

Restricted access

Chapter 4: The $250 Billion Pyramid: Analytics in Biosimilarity Determination

Edited by Steven Lucio

Restricted access

Chapter 5: The Global Biosimilars Experience

Edited by Steven Lucio

Restricted access

Chapter 6: The American Biosimilar Experience: Red, White, and Possibly Interchangeable

Edited by Steven Lucio

Restricted access

Chapter 7: Biosimilar Clinical Trial Requirements

Edited by Steven Lucio

Restricted access

Chapter 8: Immunogenicity and Pharmacovigilance in the Biosimilar Era

Edited by Steven Lucio

Restricted access

Chapter 9: The Patent Dance and the Exclusivity Shuffle

Edited by Steven Lucio

Restricted access

Conclusion: Biosimilars 2023

Edited by Steven Lucio

Restricted access

1: Introduction to the 340B Program: Current Perspectives

Andrew L. Wilson